XENE

XENE Stock-Based Compensation

$61.45MTTM · USD

Period ending:

XENE FY Stock-Based CompUSD
XENE FY Stock-Based Comp2011-12-31: $447.00K2012-12-31: $414.00K2013-12-31: $648.00K2014-12-31: $760.00K2015-12-31: $3.73M2016-12-31: $2.16M2017-12-31: $2.24M2018-12-31: $2.63M2019-12-31: $2.92M2020-12-31: $5.68M2021-12-31: $10.02M2022-12-31: $20.38M2023-12-31: $32.37M2024-12-31: $50.72M2025-12-31: $53.71M$53.71M$0.00
2011-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

XENE stock-based compensation history

Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 15 observations from Dec 31, 2011 to Dec 31, 2025.

Xenon Pharmaceuticals Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
53,707,000
50,717,000
32,372,000
20,376,000
10,017,000
5,677,000
2,924,000
2,625,000
2,236,000
2,161,000
3,729,000
760,000
648,000
414,000
447,000

Compare stock-based compensation

All XENE financial metrics · XENE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.